摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Methyl-curcumol | 4905-52-6

中文名称
——
中文别名
——
英文名称
Methyl-curcumol
英文别名
Curcumol-methylaether;8-Methoxy-2-methyl-6-methylidene-9-propan-2-yl-11-oxatricyclo[6.2.1.01,5]undecane
Methyl-curcumol化学式
CAS
4905-52-6
化学式
C16H26O2
mdl
——
分子量
250.381
InChiKey
MSXQFHGVJPYWFZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.88
  • 拓扑面积:
    18.5
  • 氢给体数:
    0
  • 氢受体数:
    2

文献信息

  • Curcumol derivatives, the compositions containing the said derivatives, and the use of the same in the manufacture of medicaments
    申请人:Wang Shulong
    公开号:US20070191360A1
    公开(公告)日:2007-08-16
    The present invention provides curcumol derivatives of the following formula (I) or pharmaceutical acceptable salts thereof: wherein, Y is selected from the group consisting of ═CHR 2 , —CH 2 R 2 , ═O, —OH or —OR 1 ;R 1 is selected from H, R, RCO or HO 3 S; and R is selected from the group consisting of H; saturated or unsaturated linear C 1-10 hydrocarbon group and the like; R 2 is selected from the group consisting of F; Cl; Br; I; H; —OH; —OR; —HSO 3 and the like; with the proviso that both R 1 and R 2 are not H. The present invention also provides anti-tumor or antiviral pharmaceutical compositions comprising said derivatives or pharmaceutical acceptable salts thereof. The present invention further provides the use of said derivatives or pharmeceutical acceptable salts thereof in the preparation of a medicament for prophylaxis and/or treatment tumor or an antiviral medicament.
    本发明提供以下式(I)的姜黄醇生物或其药学上可接受的盐:其中,Y选自 ═CHR2,—CH2R2,═O,—OH或—OR1的群组;R1选自H,R,RCO或HO3S;R选自H;饱和或不饱和的线性C1-10烃基等群组;R2选自F,Cl,Br,I,H,—OH,—OR,—HSO3等群组;但要求R1和R2均不为H。本发明还提供包含上述衍生物或其药学上可接受的盐的抗肿瘤或抗病毒药物组合物。本发明还提供使用上述衍生物或其药学上可接受的盐制备预防和/或治疗肿瘤或抗病毒药物的药物。
  • US7700584B2
    申请人:——
    公开号:US7700584B2
    公开(公告)日:2010-04-20
查看更多